153 related articles for article (PubMed ID: 35938163)
1. Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury.
Liu SB; Meng XM; Li YM; Wang JM; Guo HH; Wang C; Zhu BM
Front Cell Dev Biol; 2022; 10():946484. PubMed ID: 35938163
[TBL] [Abstract][Full Text] [Related]
2. Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A.
Meng XM; Liu SB; Deng T; Li DY; You L; Hong H; Feng QP; Zhu BM
J Cardiovasc Transl Res; 2023 Oct; 16(5):1032-1049. PubMed ID: 36947365
[TBL] [Abstract][Full Text] [Related]
3. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.
Ang SY; Uebersohn A; Spencer CI; Huang Y; Lee JE; Ge K; Bruneau BG
Development; 2016 Mar; 143(5):810-21. PubMed ID: 26932671
[TBL] [Abstract][Full Text] [Related]
4. Histone H3 lysine 4 methyltransferase KMT2D.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase KMT2D inhibits ENKTL carcinogenesis by epigenetically activating SGK1 and SOCS1.
Zhang YH; Tao Q; Zhang WY; Zhao S; Liu WP; Gao LM
Genes Genomics; 2024 Feb; 46(2):203-212. PubMed ID: 37523130
[TBL] [Abstract][Full Text] [Related]
6. Lysine methyltransferase Kmt2d regulates naive CD8
Kim J; Nguyen T; Cifello J; Ahmad R; Zhang Y; Yang Q; Lee JE; Li X; Kai Y; De S; Peng W; Ge K; Weng NP
Front Immunol; 2022; 13():1095140. PubMed ID: 36741385
[TBL] [Abstract][Full Text] [Related]
7. EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.
Yao B; Xing M; Meng S; Li S; Zhou J; Zhang M; Yang C; Qu S; Jin Y; Yuan H; Zen K; Ma C
Adv Sci (Weinh); 2024 Jan; 11(2):e2302037. PubMed ID: 38015024
[TBL] [Abstract][Full Text] [Related]
8. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract][Full Text] [Related]
9. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract][Full Text] [Related]
10. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
[TBL] [Abstract][Full Text] [Related]
11. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
Ortega-Molina A; Boss IW; Canela A; Pan H; Jiang Y; Zhao C; Jiang M; Hu D; Agirre X; Niesvizky I; Lee JE; Chen HT; Ennishi D; Scott DW; Mottok A; Hother C; Liu S; Cao XJ; Tam W; Shaknovich R; Garcia BA; Gascoyne RD; Ge K; Shilatifard A; Elemento O; Nussenzweig A; Melnick AM; Wendel HG
Nat Med; 2015 Oct; 21(10):1199-208. PubMed ID: 26366710
[TBL] [Abstract][Full Text] [Related]
12. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
[TBL] [Abstract][Full Text] [Related]
13. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K
Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062
[TBL] [Abstract][Full Text] [Related]
14.
Murugesan N; Maitituoheti M
Mol Cell Oncol; 2021; 8(5):1984827. PubMed ID: 34859145
[TBL] [Abstract][Full Text] [Related]
15. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome.
Zhang L; Pilarowski G; Pich EM; Nakatani A; Dunlop J; Baba R; Matsuda S; Daini M; Hattori Y; Matsumoto S; Ito M; Kimura H; Bjornsson HT
Mol Ther Methods Clin Dev; 2021 Mar; 20():779-791. PubMed ID: 33738331
[TBL] [Abstract][Full Text] [Related]
17. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
[TBL] [Abstract][Full Text] [Related]
18. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation.
Dhar SS; Brown C; Rizvi A; Reed L; Kotla S; Zod C; Abraham J; Abe JI; Rajaram V; Chen K; Lee M
bioRxiv; 2023 Nov; ():. PubMed ID: 37961118
[TBL] [Abstract][Full Text] [Related]
20. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]